PTPRC and Alzheimer disease: As for further differences in the immunophenotype of AD-MSCs and BM-MSCs, the surface markers CD45 (protein tyrosine phosphatase receptor type), CD133 (prominin-1), and CD144 (vascular endothelial cadherin) are expressed in BM-MSCs and not in AD-MSCs.